Back

Key takeaways, audience Q&A, and EBAC evaluation

28 August 2026 (10:40 - 10:45)
Organised by: Logo
Congress Presentation Part of: The clinical face of familial chylomicronemia syndrome: improving recognition, diagnosis, and management Lipids Open Access ESC Congress 2026 European Society of Cardiology

5 More presentations in this session

Presentation thumbnail
Introduction and overview
Professor G. Watts (Perth, AU)
Slides Video
Presentation thumbnail
Recognising clinical familial chylomicronemia syndrome: "the patient everyone thought was just noncompliant"
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Diagnosing familial chylomicronemia syndrome based on clinical criteria
Professor I. Gouni-Berthold (Cologne, DE)
Slides Video
Presentation thumbnail
A new treatment era for familial chylomicronemia syndrome: “what changes now?”
Professor G. Watts (Perth, AU)
Slides Video
Presentation thumbnail
Looking ahead at future targets
Professor G. Watts (Perth, AU)
Slides Video

Access the full session

Session thumbnail
The clinical face of familial chylomicronemia syndrome: improving recognition, diagnosis, and management
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 10:40 CET
You may be interested in
thumbnail
Congress Session
ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG)
28 August 2026
thumbnail
Congress Presentation
New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion
30 August 2026
thumbnail
Congress Session
Dyslipidaemias
30 August 2024
thumbnail
Congress Presentation
A randomised, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources